Mumps resurgences in the United States: A historical perspective on unexpected elements

Vaccine

Volumn 27, Issue 44, 2009, Pages 6186-6195

  Barskey, Albert E ^a   Glasser, John W ^a   LeBaron, Charles W ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

MMR vaccine; Mumps; Mumps outbreak; Mumps vaccine; Waning immunity

Indexed keywords

MUMPS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CROWDING; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RURAL AREA; TREND STUDY; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; GEOGRAPHY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HOUSING; HUMANS; INCIDENCE; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; MILITARY PERSONNEL; MODELS, THEORETICAL; MUMPS; POPULATION SURVEILLANCE; RISK FACTORS; STUDENTS; UNITED STATES; UNIVERSITIES; YOUNG ADULT;

EID: 70349762626     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.109     Document Type: Article

References (41)

1. Plotkin S.A., and Rubin S.A. Mumps vaccine. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 5th ed. (2008), Elsevier, Philadelphia, PA 435-465
2. Galazka A.M., Robertson S.E., and Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 77 (1999) 3-14
3. Advisory Committee on Immunization Practices. Mumps vaccine. MMWR Morb Mortal Wkly Rep 16 (1967) 430-431
4. Dayan G.H., Quinlisk M.P., Parker A.A., Barskey A.E., Harris M.L., Hill Schwartz J.M., et al. Recent resurgence of mumps in the United States. N Engl J Med 358 (2008) 1580-1589
5. Cortese M.M., Jordan H.T., Curns A.T., Quinlan P.A., Ens K.A., Denning P.M., et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 46 (2008) 1172-1180
6. Marin M., Quinlisk P., Shimabukuro T., Sawhney C., Brown C., and LeBaron C.W. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 26 (2008) 3601-3607
7. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 13 (2007) 12-17
8. Davidkin I., Jokinen S., Broman M., Leinikki P., and Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 197 (2008) 950-956
9. Barskey A., Gallagher K., Rota P., Lowe L., Kutty P., Roush S., et al. Mumps epidemiology in the United States (US) before and after the 2006 outbreak. 48th Annual ICAAC/IDSA 46th Annual Meeting. Washington, DC, October 25-28 (2008) [Abstract #V-1860]
10. Gindler J.S., Atkinson W.L., Markowitz L.E., and Hutchins S.S. Epidemiology of measles in the United States in 1989 and 1990. Pediatr Infect Dis J 11 (1992) 841-846
11. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 28 (1999) 1230-1237
12. Centers for Disease Control and Prevention. Mumps Surveillance: Report No. 2. Atlanta, GA. September; 1972.
13. Sistrom C.L., and Mergo P.J. A simple method for obtaining original data from published graphs and plots. Am J Roentgenol 174 (2000) 1241-1244
14. Simpson D.M., Ezzati-Rice T.M., and Zell E.R. Forty years and four surveys: how does our measuring measure up?. Am J Prev Med 20 4S (2001) 6-14
15. McCauley M.M., Stokley S., Stevenson J., and Fishbein D.B. Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Immunization Survey 1997-2003. J Adolesc Health 43 (2008) 540-547
16. Collins S.D. Age incidence of the common communicable diseases of children. Pub Health Rep 44 (1929) 763-826
17. Gordon J.E. The epidemiology of mumps. Am J Med Sci 200 (1940) 412-428
18. Brooks H. Epidemic parotitis as a military disease. Med Clin North Am 2 (1918) 492-505
19. Gordon J.E., and Kilham L. Ten years in the epidemiology of mumps. Am J Med Sci 218 (1949) 338-359
20. Radin M.J. The epidemic of mumps at Camp Wheeler, October, 1917 to March, 1918. Arch Int Med 22 (1918) 354-369
21. Advisory Committee on Immunization Practices. Mumps vaccine. MMWR Morb Mortal Wkly Rep 17 (1968) 419
22. Advisory Committee on Immunization Practices. Mumps vaccine. MMWR Morb Mortal Wkly Rep 26 (1977) 393-394
23. Centers for Disease Control Prevention. Mumps surveillance, January 1977 to December 1982. Issued September (1984)
24. Wharton M., Cochi S.L., Hutcheson R.H., Bistowish J.M., and Schaffner W. A large outbreak of mumps in the postvaccine era. J Infect Dis 158 (1988) 1253-1260
25. Centers for Disease Control Prevention. Mumps outbreaks on university campuses-Illinois, Wisconsin, South Dakota. MMWR Morb Mortal Wkly Rep 36 (1987) p. 496-8, 503-5
26. Cochi S.L., Preblud S.R., and Orenstein W.A. Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child 142 (1988) 499-507
27. Hersh B.S., Fine P.E., Kent W.K., Cochi S.L., Kahn L.H., Zell E.R., et al. Mumps outbreak in a highly vaccinated population. J Pediatr 119 (1991) 187-193
28. Cheek J.E., Baron R., Atlas H., Wilson D.L., and Crider Jr. R.D. Mumps outbreak in a highly vaccinated school population: evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med 149 (1995) 774-778
29. Briss P.A., Fehrs L.J., Parker R.A., Wright P.F., Sannella E.C., Hutcheson R.L., et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 169 (1994) 77-82
30. Advisory Committee on Immunization Practices. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 38 S-9 (1989) 1-18
31. Eick A.A., Hu Z., Wang Z., and Nevin R.L. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004. Vaccine 26 (2008) 494-501
32. Mancuso J.D., Krauss M.R., Audet S., and Beeler J.A. ELISA underestimates measles antibody seroprevalence in US military recruits. Vaccine 26 (2008) 4877-4878
33. Anderson R.M., and May R.M. Vaccination and herd immunity to infectious diseases. Nature 318 (1985) 323-329
34. Boxall N., Kubinyiova M., Prikazsky V., Benes C., and Castkova J. An increase in the number of mumps cases in the Czech Republic, 2005-2006. Euro Surveill 13 16 (2008) pii: 18842
35. Roberts C., Porter-Jones G., Crooker J., and Hart J. Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. Euro Surveill 14 5 (2009) pii: 19109
36. Hope-Simpson R.E. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 2 (1952) 549-554
37. Ennis F.A. Immunity to mumps in an institutional epidemic: correlation of insusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies. J Infect Dis 19 (1969) 654-657
38. LeBaron C.W., Forghani B., Beck C., Brown C., Bi D., Cossen C., et al. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 199 (2009) 552-562
39. Watson-Creed G., Saunders A., Scott J., Lowe L., Pettipas J., and Hatchette T.F. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Can Med Assoc J 175 (2006) 483-488
40. Rubin S.A., Qi L., Audet S.A., Sullivan B., Carbone K.M., Bellini W.J., et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 198 (2008) 508-515
41. Orvell C., Tecle T., Johansson B., Saito H., and Samuelson A. Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 83 (2002) 2489-2496